| KillerMD vs Bryan | 71–66 | 51.82% |
| KillerMD vs King | 78–58 | 57.35% |
| KillerMD vs Hwoarang | 54–44 | 55.10% |
| KillerMD vs Kazuya | 38–51–1 | 42.70% |
| KillerMD vs Reina | 47–38 | 55.29% |
| KillerMD vs Jin | 41–42 | 49.40% |
| KillerMD vs Steve | 37–41 | 47.44% |
| KillerMD vs Devil Jin | 34–34 | 50.00% |
| KillerMD vs Dragunov | 38–30 | 55.88% |
| KillerMD vs Lee | 40–28 | 58.82% |
| KillerMD vs Xiaoyu | 33–29 | 53.23% |
| KillerMD vs Law | 34–27 | 55.74% |
| KillerMD vs Lili | 30–29 | 50.85% |
| KillerMD vs Paul | 37–21 | 63.79% |
| KillerMD vs Yoshimitsu | 28–29 | 49.12% |
| KillerMD vs Jack-8 | 27–25 | 51.92% |
| KillerMD vs Alisa | 19–31 | 38.00% |
| KillerMD vs Jun | 27–23 | 54.00% |
| KillerMD vs Lidia | 26–20 | 56.52% |
| KillerMD vs Heihachi | 27–19 | 58.70% |
| KillerMD vs Eddy | 33–12 | 73.33% |
| KillerMD vs Leo | 17–23 | 42.50% |
| KillerMD vs Victor | 19–16 | 54.29% |
| KillerMD vs Azucena | 22–12 | 64.71% |
| KillerMD vs Lars | 18–15 | 54.55% |
| KillerMD vs Kuma | 16–16 | 50.00% |
| KillerMD vs Claudio | 14–16 | 46.67% |
| KillerMD vs Nina | 18–11 | 62.07% |
| KillerMD vs Asuka | 20–8 | 71.43% |
| KillerMD vs Feng | 18–10 | 64.29% |
| KillerMD vs Leroy | 12–16 | 42.86% |
| KillerMD vs Raven | 10–16 | 38.46% |
| KillerMD vs Shaheen | 13–10 | 56.52% |
| KillerMD vs Zafina | 5–4 | 55.56% |
| KillerMD vs Panda | 4–3 | 57.14% |
Limitations
This data is often requested to give insight into which characters you have more trouble with than others, but it is not particularly helpful for that. The main issue is that it is heavily skewed by how strong the opponents you play are.
For example, this data suggests my worst matchup is clearly vs Reina, but that's just because most of those games are vs Yagami.
There is a way to account for this being worked on. The central idea is to assign each matchup a rating vs you which adjusts based on the result, much like the regular rating but also based on the rating of each player. With this, it would give a better summary of how well you perform vs each character.
In the meantime, this page is here to present the data as requested.